Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Indian (NIFTY) Life Sciences Industry Analysis

UpdatedDec 04, 2025
DataAggregated Company Financials
Companies22
  • 7D-0.08%
  • 3M-3.1%
  • 1Y-5.9%
  • YTD-3.0%

Last week, the Life Sciences industry hasn't moved much but Anthem Biosciences is up 5.4% in that time. As for the longer term, the industry has declined 5.9% in the last year. As for the next few years, earnings are expected to grow by 22% per annum.

Industry Valuation and Performance

Has the Indian Life Sciences Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Thu, 04 Dec 2025₹3.1t₹342.6b₹48.4b33x64.3x9.1x
Sat, 01 Nov 2025₹3.3t₹331.4b₹45.5b45x72.1x9.9x
Mon, 29 Sep 2025₹3.0t₹331.4b₹45.5b45.4x66.2x9.1x
Wed, 27 Aug 2025₹3.2t₹331.4b₹45.5b40.9x70.4x9.7x
Fri, 25 Jul 2025₹3.3t₹320.3b₹41.8b52.6x79x10.3x
Sun, 22 Jun 2025₹2.8t₹299.7b₹37.2b46x76.1x9.5x
Tue, 20 May 2025₹2.8t₹294.5b₹32.8b49x85.3x9.5x
Thu, 17 Apr 2025₹2.6t₹287.4b₹30.8b47.9x83.5x8.9x
Sat, 15 Mar 2025₹2.5t₹287.4b₹30.8b47x79.9x8.6x
Mon, 10 Feb 2025₹2.7t₹286.2b₹30.2b52.8x89.7x9.4x
Wed, 08 Jan 2025₹2.6t₹269.1b₹30.1b55.6x84.8x9.5x
Fri, 06 Dec 2024₹2.5t₹254.2b₹28.8b54x85.3x9.7x
Sun, 03 Nov 2024₹2.4t₹247.9b₹26.0b48.8x91.8x9.6x
Tue, 01 Oct 2024₹2.3t₹247.6b₹26.3b50.2x86.9x9.2x
Thu, 29 Aug 2024₹2.1t₹247.6b₹26.3b47.4x81x8.6x
Sat, 27 Jul 2024₹1.9t₹201.7b₹23.8b41x79.8x9.4x
Mon, 24 Jun 2024₹1.7t₹198.0b₹23.7b33.7x73.7x8.8x
Wed, 22 May 2024₹1.6t₹193.7b₹21.6b34.8x73.9x8.2x
Fri, 19 Apr 2024₹1.4t₹168.5b₹18.6b28.7x75.4x8.3x
Sun, 17 Mar 2024₹1.3t₹168.5b₹18.6b29x71.3x7.9x
Tue, 13 Feb 2024₹1.4t₹168.5b₹19.6b33.5x72.9x8.5x
Thu, 11 Jan 2024₹1.4t₹155.9b₹18.1b23.8x79.2x9.2x
Sat, 09 Dec 2023₹1.4t₹155.9b₹18.1b23.2x75.1x8.7x
Mon, 06 Nov 2023₹1.3t₹156.1b₹19.9b23.3x63.1x8x
Wed, 04 Oct 2023₹1.4t₹154.7b₹19.7b26.5x71.8x9.1x
Fri, 01 Sep 2023₹1.4t₹154.7b₹19.7b26.5x68.7x8.8x
Sun, 30 Jul 2023₹1.4t₹158.1b₹23.2b31.1x60.9x8.9x
Tue, 27 Jun 2023₹1.3t₹157.2b₹23.0b28.9x57.1x8.4x
Thu, 25 May 2023₹1.3t₹158.1b₹22.6b33x55.6x8x
Sat, 22 Apr 2023₹1.2t₹159.5b₹28.4b32.4x41.6x7.4x
Mon, 20 Mar 2023₹1.0t₹159.5b₹28.4b30.9x36.9x6.6x
Wed, 15 Feb 2023₹1.0t₹159.5b₹28.4b33.8x36.8x6.5x
Fri, 13 Jan 2023₹1.2t₹164.9b₹34.5b29.3x34.9x7.3x
Sun, 11 Dec 2022₹1.2t₹164.9b₹34.5b30x34.5x7.2x
Price to Earnings Ratio

34.5x


Total Market Cap: ₹1.2tTotal Earnings: ₹34.5bTotal Revenue: ₹164.9bTotal Market Cap vs Earnings and Revenue0%0%0%
Indian Life Sciences Industry Price to Earnings3Y Average 69.6x202320242025
Current Industry PE
  • Investors are pessimistic on the Indian Life Sciences industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 64.3x which is lower than its 3-year average PE of 69.6x.
  • The industry is trading close to its 3-year average PS ratio of 8.7x.
Past Earnings Growth
  • The earnings for companies in the Life Sciences industry have grown 12% per year over the last three years.
  • Revenues for these companies have grown 28% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the Indian Healthcare industry?

IN Market-1.19%
Healthcare-0.79%
Life Sciences-0.08%
Clinical Research and Equipment-0.08%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
ANTHEM Anthem Biosciences₹662.005.4%
+₹19.0b		n/aPE72x
ONESOURCE OneSource Specialty Pharma₹1.67k4.6%
+₹8.4b		n/aPE470x
INDGN Indegene₹535.052.2%
+₹2.8b		-14.8%PE28.8x
SYNGENE Syngene International₹642.350.4%
+₹935.5m		-30.8%PE54.6x
INFLUX Influx Healthtech₹242.056.3%
+₹331.1m		n/aPE31.6x

Latest News

AKUMS
₹420.30
Akums Drugs and Pharmaceuticals
7D
0.2%
1Y
-31.0%

AKUMS: Zambian Expansion Will Drive Earnings Momentum And Future Market Reach

Analysts have maintained their price target for Akums Drugs and Pharmaceuticals at ₹638.33, noting only minimal adjustments to underlying assumptions such as the discount rate and future earnings expectations. What's in the News The board of Akums Drugs and Pharmaceuticals approved an investment of USD 24 million (INR 2000 million approx.) in its Zambian subsidiary to establish a manufacturing facility and expand business in African markets (Board Meeting, Nov 13, 2025).
TARSONS
₹227.89
Tarsons Products
7D
1.0%
1Y
-48.9%
INNOVACAP
₹711.80
Innova Captab
7D
-1.9%
1Y
-36.3%

INNOVACAP: Improved Revenue Outlook Will Drive Bullish Momentum Ahead

Analysts have maintained their fair value price target for Innova Captab at ₹808.5. They cited minor adjustments in key financial assumptions, including the discount rate, revenue growth, and profit margin, to reflect updated expectations for the company's future performance. What's in the News Innova Captab Limited has scheduled a Board Meeting on November 7, 2025.
DIVISLAB
₹6,469.00
Divi's Laboratories
7D
-0.3%
1Y
6.1%

DIVISLAB: Upcoming Board Decisions And Modest Earnings Improvements Will Shape Outlook

Analysts have raised their fair value estimate for Divi's Laboratories from ₹6,433 to ₹6,785, citing modest improvements in revenue growth and profit margin expectations. What's in the News A board meeting is scheduled for November 7, 2025, at 10:30 IST to consider and approve unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2025 (Key Developments).
524394
₹608.60
Vimta Labs
7D
-1.6%
1Y
32.8%
INDGN
₹535.05
Indegene
7D
2.2%
1Y
-14.8%

INDGN: Upcoming Board Meeting and Expansions Will Drive Continued Momentum

Analysts have slightly adjusted their price target for Indegene, lowering it from ₹609.57 to ₹608.14 as a result of modest revisions in growth and profitability assumptions. What's in the News A board meeting is scheduled for October 30, 2025 to consider consolidated and standalone financial results as well as ESOP/RSU allotments (Board Meeting).
INFLUX
₹242.05
Influx Healthtech
7D
6.3%
1Y
n/a

Earnings Tell The Story For Influx Healthtech Limited (NSE:INFLUX) As Its Stock Soars 27%

Nov 19
Earnings Tell The Story For Influx Healthtech Limited (NSE:INFLUX) As Its Stock Soars 27%
SAILIFE
₹867.50
Sai Life Sciences
7D
-1.0%
1Y
n/a

Impressive Earnings May Not Tell The Whole Story For Sai Life Sciences (NSE:SAILIFE)

Nov 14
Impressive Earnings May Not Tell The Whole Story For Sai Life Sciences (NSE:SAILIFE)
ONESOURCE
₹1,667.80
OneSource Specialty Pharma
7D
4.6%
1Y
n/a
530239
₹171.40
Suven Life Sciences
7D
-0.9%
1Y
28.2%
DCAL
₹228.56
Dishman Carbogen Amcis
7D
-4.8%
1Y
-13.9%
ANTHEM
₹662.00
Anthem Biosciences
7D
5.4%
1Y
n/a
SYNGENE
₹642.35
Syngene International
7D
0.4%
1Y
-30.8%

Syngene International Limited (NSE:SYNGENE) Just Reported Second-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?

Nov 08
Syngene International Limited (NSE:SYNGENE) Just Reported Second-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?
544184
₹123.50
Borosil Scientific
7D
-2.6%
1Y
-32.9%
FABTECH
₹234.82
Fabtech Technologies
7D
-3.1%
1Y
n/a
539267
₹21.57
Samsrita Labs
7D
4.4%
1Y
-5.4%